PRPS2 and neoplasm: To evaluate the impact of PRPS2 knockdown on tumor growth in vivo, we established a subcutaneous xenograft tumor model in athymic nude mice by injecting PC‐3 cells infected with shRNA targeting PRPS2 or NC PC‐3 cells.